Quick Answer
IMMUCELL CORP /DE/ reported Net Income of -$1.04 million for fiscal year 2025.
IMMUCELL CORP /DE/ Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$1.04M | +51.8% |
| 2024 | -$2.16M | +62.7% |
| 2023 | -$5.77M | -131.6% |
| 2022 | -$2.49M | -3085.3% |
| 2021 | -$78.3K | +92.3% |
| 2020 | -$1.02M | +21.1% |
| 2019 | -$1.30M | +44.2% |
| 2018 | -$2.32M | -1280.7% |
| 2017 | -$168.1K | -133.1% |
| 2016 | $508.4K | -58.1% |
| 2015 | $1.21M | +825.8% |
| 2014 | -$167.2K | -242.4% |
| 2013 | $117.4K | +31.2% |
| 2012 | $89.5K | +121.9% |
| 2011 | -$409.5K | -6.5% |
| 2010 | -$384.7K | -77.7% |
| 2009 | -$216.5K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$139.7K | +80.1% | -127.8% |
| June 30, 2025 | $501.9K | +132.8% | -65.3% |
| March 31, 2025 | $1.45M | +430.5% | +306.2% |
| September 30, 2024 | -$701.7K | +25.4% | +54.2% |
| June 30, 2024 | -$1.53M | -11.0% | -249.8% |
| March 31, 2024 | -$437.9K | +81.1% | +53.4% |
| September 30, 2023 | -$940.0K | -43.5% | +31.9% |
| June 30, 2023 | -$1.38M | -101.7% | +40.4% |
- IMMUCELL CORP /DE/ showed an increase of +51.8% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, IMMUCELL CORP /DE/’s net income has declined by 380.4% (from -$216.5 thousand to -$1.04 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: